Ph.D., statistics, Harvard University; B.A., statistics, Peking University
Summary of Experience
Dr. Han is a statistician with broad experience in health economics and outcomes research. Her expertise includes statistical methodology development and its application in real-world health care data. She has consulted on a wide range of therapeutic areas, including mental health, cardiovascular, metabolic disease, and other chronic disease. Dr. Han has worked on multiple projects worldwide and in China, including EMR database analysis, the design of chart review questionnaires, analysis of claims data, network meta-analysis, indirect comparison, individualized medicine, and economic modeling. In addition to data analysis, Dr. Han is also experienced in development of novel statistical methods for health care research. Her work has been published in a leading peer-reviewed journal.
Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer in the United States
Journal of Medical Economics. Jun 2018;21(6):577-586